We thank Hamad Medical Corporation for supporting academic research and the medical staff involved in the care of COVID-19 patients. Publication charges for this article were waived due to the ongoing pandemic of COVID-19.
Wu Z, McGoogan JM, 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. J Am Med Assoc 323: 1239–1242.
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R, 2020. Features, Evaluation and Treatment Coronavirus (COVID-19). Napoli, Italy: StatPearls Publishing. Available at: http://www.ncbi.nlm.nih.gov/pubmed/32150360. Accessed December 18, 2020.
Zapor M, 2020. Persistent detection and infectious potential of SARS-CoV-2 virus in clinical specimens from COVID-19 patients. Viruses 12: 1384.
Li TZ 2020. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19. J Med Virol 93: 506–512.
Baj A, Azzi L, Dalla Gasperina D, Genoni A, Tamborini A, Gambarini C, Carcano G, Grossi P, Sessa F, 2020. Pilot study: long-term shedding of SARS-CoV-2 in urine: a threat for dispersal in wastewater. Front Public Health 8: 569209.
Morone G 2020. Incidence and persistence of viral shedding in COVID-19 post-acute patients with negativized pharyngeal swab: a systematic review. Front Med 7: 562.
Zheng S 2020. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ 369: m1443.
Fang Z, Zhang Y, Hang C, Ai J, Li S, Zhang W, 2020. Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients. J Infect 81: 147–178.
Xu K 2020. Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19). Clin Infect Dis 71: 799–806.
Yan D, Liu XY, Zhu YN, Huang L, Dan BT, Zhang GJ, Gao YH, 2020. Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection. Eur Respir J 56: 2000799.
Noh JY, Yoon JG, Seong H, Choi WS, Sohn JW, Cheong HJ, Kim WJ, Song JY, 2020. Asymptomatic infection and atypical manifestations of COVID-19: comparison of viral shedding duration. J Infect 81: 816–846.
Avanzato VA 2020. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell 183: 1901–1912.e9.
Nakajima Y, Ogai A, Furukawa K, Arai R, Anan R, Nakano Y, Kurihara Y, Shimizu H, Misaki T, Okabe N, 2020. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient. J Infect Chemother 27: 387–389.
Huang I, Lim MA, Pranata R, 2020. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression: diabetes and COVID-19. Diabetes Metab Syndr Clin Res Rev 14: 395–403.
Bullard J 2020. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis. doi: 10.1093/cid/ciaa638.
Singanayagam A, Patel M, Charlett A, Bernal JL, Saliba V, Ellis J, Ladhani S, Zambon M, Gopal R, 2020. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Eurosurveillance 25: 1.
CDC, 2020. Interim Guidelines for Clinical Specimens for COVID-19. Available at: https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html. Accessed December 19, 2020.
WHO, 2020. Criteria for releasing COVID-19 patients from isolation. Available at: https://www.who.int/publications/i/item/criteria-for-releasing-covid-19-patients-from-isolation. Accessed December 19, 2020.